The TTS Global Initiative is the leading international platform for early stage life sciences tech transfer, licensing, partnering, and investment. It includes an interlinked global series of exclusive summits, the proprietary TTS Innovation Bank for the submission and dissemination of technology offerings, and counts amongst its members the leading stakeholders in the industry worldwide.
The TTS Global Initiative is an important community for entrepreneurial researchers & innovators; university, institute, clinic and hospital Tech Transfer Offices; early stage start-ups; biotech and pharmaceutical corporations, and investors alike. Inaugurated in 2007, the initiative enables all stakeholders in the early stage sector to successfully network, collaborate and form partnerships that can help drive forward innovative technologies to the commercial markets.
The TTS Global Initiative 2013 includes:
Please check back soon for the full websites and details for each of these summits.
To become a part of the TTS Global Initiative, win a free VIP pass for the TTS of your choice, stay informed on the TTS Global Initiative, and receive key updates, discounts, and special offers: join here
September 27, 2012
Chris Austin, Director, NIH National Center for Advancing Translational Science (NCATS) to deliver a keynote presentation at TTS North America 2012.
September 24, 2012
We are pleased to confirm the Steven Tregay, CEO of Forma Therapeutics, will deliver a keynote presentation at the TTS North America 2012.
Founded in 2008 and… more
June 13, 2012
The Licensing Executive Society (LES) Britain & Ireland has officially become a Partner of the Global Tech Transfer Initiative, and will be present at the TTS… more
December 7, 2013